Policy and Advocacy Shorts with Keith Wonnacott, PhD
Channel | Publish Date | Thumbnail & View Count | Download Video |
---|---|---|---|
Publish Date not found | 0 Views |
Keith Wonnacott, PhD, vice president of regulatory affairs at Lexeo Therapeutics, shares insights on ASGCT's role in connecting academia and industry, and discusses the evolution of regulatory approaches in cell and gene therapy.
Please take the opportunity to connect and share this video with your friends and family if you find it helpful.